Clinical and ultrasound markers of significant liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and arterial hypertension
In patients with MASLD and arterial hypertension, significant fibrosis was present in one in four patients, while severe fibrosis was present in more than one in ten, and only a coarse liver parenchymal echotexture was an independent ultrasonographic predictor of significant fibrosis according to multivariable logistic...